1. FDA Committee Votes 6-6 on Durect's Non-Opioid Pain Drug — Eli Lilly targets quarterly deals of $1 billion-$5 billion in 2020 — Novo Nordisk's Ozempic wins FDA label boost with CV indication — See more on our front page news TRY TWO WEEKS OF OUR EMAIL NEWS HEADLINES FOR FREE
    Dismiss Notice
  2. Think you have witnessed fraud?Ask a Whistleblower Attorney -- a chance to discuss whistleblower-related legal issues with practicing whistleblower attorneys.
    Dismiss Notice

Review time

Discussion in 'MWI' started by anonymous, Nov 10, 2019 at 4:29 PM.

Tags: Add Tags
  1. anonymous

    anonymous Guest

    Wow how time flies, it’s already annual review time again - Anyone get a pink slip, or PIP?? Heard that ABC influence is negatively affecting the reviews, no matter what MWI management may think, and there’s really not many legacy MWI upper management left in Boise to have our back.
     

  2. anonymous

    anonymous Guest

    I haven’t heard a thing. Business as usual. What’s supposed to happening?